Soluble CD14 as a predictor of subsequent development of recurrent wheezing in hospitalized young children with respiratory syncytial virus–induced bronchiolitis
- 31 May 2004
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 92 (5), 545-548
- https://doi.org/10.1016/s1081-1206(10)61762-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthmaThe Pediatric Infectious Disease Journal, 2003
- Exposure to farming in early life and development of asthma and allergy: a cross-sectional surveyThe Lancet, 2001
- Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor ComplexJournal of Biological Chemistry, 2001
- CD14-dependent airway neutrophil response to inhaled LPS: Role of atopyJournal of Allergy and Clinical Immunology, 2001
- CD14: a bridge between innate immunity and adaptive IgE responsesInnate Immunity, 2001
- Hepatocytes Contribute to Soluble CD14 Production, and CD14 Expression Is Differentially Regulated in Hepatocytes and MonocytesPublished by Elsevier ,2000
- Increased Circulating Soluble Cd14 Is Associated With High Mortality In Gram-Negative Septic ShockThe Journal of Infectious Diseases, 1995
- CD14 Is a pattern recognition receptorImmunity, 1994
- Elevated levels of soluble CD 14 in serum of patients with systemic lupus erythematosusClinical and Experimental Immunology, 1994
- Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy.BMJ, 1982